Cookie Policy

We've put some small files called essential cookies on your device to help our site work on your browser.
We also use analytical cookies to help up improve our website by collecting and reporting information on it's usage.

You can read more above this on our Privacy Policy page.

I'm ok with analytical cookies Do not use analytics cookies

2020 Annual Report and 2021 AGM Notice

13 May 2021

Shield Therapeutics plc, announces that the following documents have now been sent to shareholders:

  • Annual Report and Accounts for the year ended 31 December 2020
  • Notice of Annual General Meeting (“AGM”) 2021

In accordance with AIM Rule 26, these documents are also available to view on the Company’s website   www.shieldtherapeutics.com/investors/corporate-documents/.

The AGM is scheduled to be held at 2.00pm BST on Thursday 17 June 2021. Due to the continuing COVID-19 restrictions, this meeting will be held virtually, and attendance will be available online and telephonically.

The Company will provide a facility for shareholders to join the AGM online and telephonically and there will be an opportunity for shareholders to ask questions. In order to facilitate the process, the Board would request that shareholders register for the meeting and submit questions in advance, before 2.00pm (BST) on 15 June 2021.

To register for dial-in details and to submit any questions please contact Walbrook PR via email at shield@walbrookpr.com or call +44 (0)20 7933 8787.

For further details click here.

Back to news